Fortress Biotech Announces Closing of $10.0 Million Public Offering
The warrants are immediately exercisable at a price of $1.70 per share and expire five years from the date of issuance.
- The warrants are immediately exercisable at a price of $1.70 per share and expire five years from the date of issuance.
- Certain directors and officers of the Company participated in the offering and purchased an aggregate amount of approximately $2.9 million of units at the same purchase price.
- The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are approximately $10.0 million.
- The offering was made only by means of a prospectus supplement which is a part of the effective registration statement.